Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
PBMs’ vertical integration allows them to dictate cancer treatment decisions, from drug selection to delivery methods, potentially compromising patient care and increasing costs.
Hematology/Oncology July 29th 2024
GoodRx for Healthcare Professionals
Telemedicine significantly enhances patient access to care by offering a wide range of services from general health to specialized treatments, all at potentially lower costs compared to traditional visits.
All Specialties June 24th 2024
Clinical Advisor
Higher telehealth use correlates with increased healthcare utilization and costs, indicating that while telehealth improves access, it may also lead to higher rates of ambulatory care-sensitive hospitalizations.
All Specialties May 28th 2024
First Report Managed Care
The Inflation Reduction Act’s out-of-pocket cap on Medicare Part D spending marks a pivotal shift in healthcare economics, potentially altering prescription drug cost dynamics for millions of enrollees. Physicians should be aware of these changes to better support and inform their patients navigating these new financial landscapes.
All Specialties March 13th 2024
In an era where specialty drug costs soar, Alternative Funding Programs present a complex solution, balancing cost containment with patient access to essential medications. These programs, while offering potential savings, may also introduce treatment delays and increased financial burdens for patients.
All Specialties March 11th 2024
Pharmacy Today
The study’s findings underscore the importance of addressing the high cost of insulin. Despite new products and discounts entering the market, one in four patients still report cost as a barrier to accessing their necessary insulin.
Clinical Pharmacology October 30th 2023